100 related articles for article (PubMed ID: 8185338)
1. [Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section)].
Tominaga T; Nomura Y; Adachi I; Aoyama H; Nagao K; Mitsuyama S; Nakamura Y; Ogita M; Sano M; Takashima S
Gan To Kagaku Ryoho; 1994 May; 21(6):809-16. PubMed ID: 8185338
[TBL] [Abstract][Full Text] [Related]
2. [Early phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section].
Tominaga T; Nomura Y; Adachi I; Takashima S; Kimura M; Koyama H; Toge T; Tamura K; Hayasaka H; Kunii Y
Gan To Kagaku Ryoho; 1994 May; 21(6):801-8. PubMed ID: 8185337
[TBL] [Abstract][Full Text] [Related]
3. [Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)].
Tominaga T; Nomura Y; Horikoshi N; Takashima S; Kimura M; Koyama H; Kikkawa N; Toge T; Mitsuyama S; Morimoto T; Enomoto K; Wada T; Kimishima I; Niitani H;
Gan To Kagaku Ryoho; 2005 Jul; 32(7):983-90. PubMed ID: 16044960
[TBL] [Abstract][Full Text] [Related]
4. [Phase I clinical study on new vinca alkaloid derivative, KW-2307 (vinorelbine). KW-2307 Study Group].
Niitani H; Furuse K; Fukuoka M; Hasegawa K; Taguchi T
Gan To Kagaku Ryoho; 1994 Feb; 21(2):177-87. PubMed ID: 8311488
[TBL] [Abstract][Full Text] [Related]
5. [Early phase II clinical study of KW-2307 in patients with lung cancer. Lung Cancer Section in KW-2307 Study Group].
Furuse K; Ohta M; Fukuoka M; Kurita Y; Kobayashi K; Hasegawa K; Kimura I; Fujii M; Yoshida S; Kitamura S
Gan To Kagaku Ryoho; 1994 May; 21(6):785-93. PubMed ID: 8185336
[TBL] [Abstract][Full Text] [Related]
6. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
[TBL] [Abstract][Full Text] [Related]
7. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
8. [Late phase II clinical study of KW-2307 in previously untreated patients with non-small cell lung cancer. KW-2307 Study Group (Lung Cancer Group)].
Furuse K; Kinuwaki E; Motomiya M; Nishiwaki H; Hasegawa K; Kobayashi K; Kurita Y; Ohta K; Fukuoka M; Nakajima S
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1941-7. PubMed ID: 8085845
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.
Fumoleau P; Delgado FM; Delozier T; Monnier A; Gil Delgado MA; Kerbrat P; Garcia-Giralt E; Keiling R; Namer M; Closon MT
J Clin Oncol; 1993 Jul; 11(7):1245-52. PubMed ID: 8315421
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
Toussaint C; Izzo J; Spielmann M; Merle S; May-Levin F; Armand JP; Lacombe D; Tursz T; Sunderland M; Chabot GG
J Clin Oncol; 1994 Oct; 12(10):2102-12. PubMed ID: 7931480
[TBL] [Abstract][Full Text] [Related]
12. A phase II, multicentre, UK study of vinorelbine in advanced breast cancer.
Twelves CJ; Dobbs NA; Curnow A; Coleman RE; Stewart AL; Tyrrell CJ; Canney P; Rubens RD
Br J Cancer; 1994 Nov; 70(5):990-3. PubMed ID: 7947109
[TBL] [Abstract][Full Text] [Related]
13. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
Taguchi T; Mori S; Abe R; Hasegawa K; Morishita Y; Tabei T; Sasaki Y; Fujita M; Enomoto K; Hamano K
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2625-32. PubMed ID: 7979423
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of vintriptol, a tryptophan ester of vinblastine.
Oosterkamp HM; Vlasveld LT; Wanders J; Beijnen JH; van Tellingen O; Dubbelman AC; Simonetti GP; Franklin HR; Vermorken JB; Ten Bokkel Huinink WW
Eur J Cancer; 1991; 27(10):1222-6. PubMed ID: 1835590
[TBL] [Abstract][Full Text] [Related]
15. [Phase-I clinical study of KW-2307 combined with cisplatin in non-small cell lung cancer patients].
Yamamoto M; Ariyoshi Y; Hasegawa K; Kobayashi K; Fukuoka M; Kurita Y; Sakuma A; Furuse K; Niitani H
Gan To Kagaku Ryoho; 1994 Jun; 21(7):993-9. PubMed ID: 8002639
[TBL] [Abstract][Full Text] [Related]
16. Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes.
Toi M; Saeki T; Aogi K; Sano M; Hatake K; Asaga T; Tokuda Y; Mitsuyama S; Kimura M; Kobayashi T; Tamura M; Tabei T; Shin E; Nishimura R; Ohno S; Takashima S
Jpn J Clin Oncol; 2005 Jun; 35(6):310-5. PubMed ID: 15930037
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of vindesine in patients with advanced breast cancer.
Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
Goa KL; Faulds D
Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
[TBL] [Abstract][Full Text] [Related]
19. Phase-II study of Navelbine in advanced breast cancer.
Canobbio L; Boccardo F; Pastorino G; Brema F; Martini C; Resasco M; Santi L
Semin Oncol; 1989 Apr; 16(2 Suppl 4):33-6. PubMed ID: 2711204
[No Abstract] [Full Text] [Related]
20. Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
Vokes EE; Rosenberg RK; Jahanzeb M; Craig JB; Gralla RJ; Belani CP; Jones SE; Bigley JW; Hohneker JA
J Clin Oncol; 1995 Mar; 13(3):637-44. PubMed ID: 7533824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
